|
FR2470599A1
(fr)
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
|
US5000886A
(en)
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
|
US5122519A
(en)
|
1989-06-27 |
1992-06-16 |
American Cyanamid Company |
Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
|
|
JPH0624959A
(ja)
|
1991-10-04 |
1994-02-01 |
Bayer Yakuhin Kk |
胃内浮遊型薬物徐放性固形製剤
|
|
US5538954A
(en)
|
1994-06-24 |
1996-07-23 |
A/S Dumex (Dumex Ltd.) |
Salts of tetracyclines
|
|
US6077533A
(en)
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
US6245350B1
(en)
|
1994-12-16 |
2001-06-12 |
Warner-Lambert Company |
Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
|
|
ATE194486T1
(de)
|
1994-12-16 |
2000-07-15 |
Warner Lambert Co |
Verfahren zur einkapselung von tabletten in eine kapsel und feststoff-dosierungsformen erhaltbar durch dieses verfahren
|
|
JPH0995440A
(ja)
|
1995-09-29 |
1997-04-08 |
Roussel Morishita Kk |
徐放性製剤およびその製造方法
|
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
EP0910348B1
(en)
|
1996-05-23 |
2003-04-02 |
Samyang Corporation |
Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
|
|
US5789395A
(en)
|
1996-08-30 |
1998-08-04 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
|
|
US5780055A
(en)
|
1996-09-06 |
1998-07-14 |
University Of Maryland, Baltimore |
Cushioning beads and tablet comprising the same capable of forming a suspension
|
|
US20070092563A1
(en)
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
DE69831335T3
(de)
|
1997-06-06 |
2015-01-15 |
Depomed, Inc. |
Im magen verweilende orale dosierungsformen von wasserlöslichen arzneistoffen mit kontrollierter freisetzung
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
SK284690B6
(sk)
|
1997-06-11 |
2005-09-08 |
The Procter And Gamble Company |
Ústna dávkovacia forma na zvýšenie ochrany horného tráviaceho traktu
|
|
US7201923B1
(en)
|
1998-03-23 |
2007-04-10 |
General Mills, Inc. |
Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
|
|
DE69941212D1
(de)
|
1998-03-23 |
2009-09-17 |
Gen Mills Inc |
Verkapselung von komponenten in essbaren produkten
|
|
PT1119345E
(pt)
|
1998-10-09 |
2009-07-27 |
Gen Mills Inc |
Encapsulação de componentes líquidos sensíveis numa matriz para obter partículas discretas de longa conservação
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
EP1161956A4
(en)
|
1999-03-17 |
2005-03-16 |
Daiichi Seiyaku Co |
DRUG COMPOSITIONS
|
|
US20030077301A1
(en)
|
1999-12-16 |
2003-04-24 |
Maibach Howard I. |
Topical pharmaceutical composition for the treatment of inflammatory dermatoses
|
|
OA12124A
(en)
|
1999-12-23 |
2006-05-05 |
Pfizer Prod Inc |
Pharmmaceutical compositions providing enhanced drug concentrations.
|
|
US6638532B2
(en)
|
2000-02-24 |
2003-10-28 |
Advancis Pharmaceutical Corp. |
Tetracycline—doxycycline antibiotic composition
|
|
US6730320B2
(en)
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
FR2811571B1
(fr)
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
|
RU2281757C2
(ru)
*
|
2000-09-19 |
2006-08-20 |
Дайити Фармасьютикал Ко., Лтд. |
Фармацевтическая композиция
|
|
US6497901B1
(en)
|
2000-11-02 |
2002-12-24 |
Royer Biomedical, Inc. |
Resorbable matrices for delivery of bioactive compounds
|
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
|
IN192750B
(enExample)
|
2000-12-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
|
US7211267B2
(en)
|
2001-04-05 |
2007-05-01 |
Collagenex Pharmaceuticals, Inc. |
Methods of treating acne
|
|
CA2447008A1
(en)
|
2001-04-05 |
2002-10-24 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US20030104052A1
(en)
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
AU2002359768A1
(en)
|
2001-12-20 |
2003-10-27 |
Middlebrook Pharmaceuticals, Inc. |
Antibiotic product, use and formulation thereof
|
|
KR100540035B1
(ko)
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
|
WO2003075852A2
(en)
|
2002-03-07 |
2003-09-18 |
Advancis Pharmaceuticals Corporation |
Antibiotic composition
|
|
AUPS167602A0
(en)
|
2002-04-12 |
2002-05-16 |
F.H. Faulding & Co. Limited |
An improved modified release preparation
|
|
US6958161B2
(en)
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
|
US8192749B2
(en)
|
2003-04-16 |
2012-06-05 |
Galderma Laboratories Inc. |
Methods of simultaneously treating ocular rosacea and acne rosacea
|
|
EP2368557A1
(en)
|
2002-04-16 |
2011-09-28 |
Collagenex Pharmaceuticals, Inc. |
Methods of simultaneously treating ocular rosacea and acne rosacea
|
|
AU2003243607A1
(en)
|
2002-06-20 |
2004-01-06 |
Royer Biomedical, Inc. |
Resorbable matrices with coatings for delivery of bioactive compounds
|
|
KR101041767B1
(ko)
|
2002-06-25 |
2011-06-17 |
다케다 야쿠힌 고교 가부시키가이샤 |
서방성 조성물의 제조 방법
|
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
EP1417958A1
(en)
|
2002-11-08 |
2004-05-12 |
Pari GmbH |
Wet granulation process
|
|
EP1589951B1
(en)
|
2003-01-03 |
2017-08-09 |
Supernus Pharmaceuticals, Inc. |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
MXPA05010636A
(es)
|
2003-04-04 |
2005-12-12 |
Pharmacia Corp |
Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
|
|
US7749532B2
(en)
|
2003-04-07 |
2010-07-06 |
Supernus Pharmaceuticals, Inc. |
Once daily formulations of tetracyclines
|
|
JP2006523703A
(ja)
|
2003-04-14 |
2006-10-19 |
シャイア ラボラトリーズ，インコーポレイテッド |
吸収ウィンドウ問題を克服するための、活性剤をバッカルまたは舌下の位置から放出する薬学的組成物
|
|
CA2529503A1
(en)
|
2003-06-20 |
2004-12-29 |
Royer Biomedical, Inc. |
Drug polymer complexes
|
|
AU2004261143B2
(en)
|
2003-07-25 |
2009-11-05 |
Allergan Pharmaceuticals International Limited |
A doxycycline metal complex in a solid dosage form
|
|
WO2005016311A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
|
US20050049210A1
(en)
|
2003-08-27 |
2005-03-03 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
|
JP2007509954A
(ja)
|
2003-10-27 |
2007-04-19 |
ダウ コーニング コーポレーション |
局所的な適用のための徐放性の組成物及び基体へ活性な作用薬を配送する方法
|
|
WO2005046651A1
(en)
|
2003-11-12 |
2005-05-26 |
Ranbaxy Laboratories Limited |
Liquid filled capsules of doxycycline
|
|
EP1691787B1
(en)
|
2003-12-04 |
2008-07-02 |
Pfizer Products Inc. |
Method for making pharmaceutical multiparticulates
|
|
DE10358748A1
(de)
|
2003-12-12 |
2005-07-14 |
Lts Lohmann Therapie-Systeme Ag |
Darreichungsform basierend auf vernetzten hydrophilen Polymeren
|
|
US7410480B2
(en)
|
2004-04-21 |
2008-08-12 |
Acclarent, Inc. |
Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
|
|
JP5154924B2
(ja)
|
2004-05-11 |
2013-02-27 |
エガレット エイ／エス |
ジェランガムを含む膨張可能な投与形態
|
|
US7906140B2
(en)
|
2004-06-17 |
2011-03-15 |
Virun, Inc. |
Compositions for mucosal delivery of agents
|
|
US20080161273A1
(en)
|
2004-10-20 |
2008-07-03 |
Galderma Research & Development |
Method of Using Adapalene in Acne Maintenance Therapy
|
|
US8715724B2
(en)
|
2004-10-29 |
2014-05-06 |
Mayne Pharma International Pty Ltd |
Tabletting process
|
|
US20060147491A1
(en)
|
2005-01-05 |
2006-07-06 |
Dewitt David M |
Biodegradable coating compositions including multiple layers
|
|
US9205047B2
(en)
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
|
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
US20100215744A1
(en)
|
2008-08-06 |
2010-08-26 |
Medicis Pharmaceutical Corporation |
Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
|
|
US20080242642A1
(en)
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
WO2007036952A2
(en)
|
2005-07-01 |
2007-04-05 |
Rubicon Research Pvt Ltd. |
Novel sustained release dosage form
|
|
AU2006264407B2
(en)
|
2005-07-04 |
2012-08-30 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
|
WO2007052289A2
(en)
|
2005-07-22 |
2007-05-10 |
Rubicon Research Pvt Ltd. |
Novel dispersible tablet composition
|
|
RU2385712C2
(ru)
|
2005-08-24 |
2010-04-10 |
Рубикон Рисёч Пвт Лтд. |
Рецептура с контролируемым высвобождением
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
WO2007038867A1
(en)
|
2005-10-04 |
2007-04-12 |
Mistral Pharma Inc. |
Controlled-release oral dosage form
|
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
|
EP1991236A2
(en)
|
2006-01-24 |
2008-11-19 |
Paratek Pharmaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
|
CA2648280C
(en)
|
2006-04-03 |
2014-03-11 |
Isa Odidi |
Controlled release delivery device comprising an organosol coat
|
|
WO2007133583A2
(en)
|
2006-05-09 |
2007-11-22 |
Mallinckrodt Inc. |
Zero-order modified release solid dosage forms
|
|
CA2655596C
(en)
|
2006-06-27 |
2011-10-25 |
Biovail Laboratories International Srl |
Multiparticulate osmotic delivery system
|
|
US20080014257A1
(en)
|
2006-07-14 |
2008-01-17 |
Par Pharmaceutical, Inc. |
Oral dosage forms
|
|
US20080268045A1
(en)
|
2006-11-09 |
2008-10-30 |
Proprius Pharmaceuticals, Inc. |
Sustained release methotrexate formulations and methods of use thereof
|
|
SI2120963T1
(sl)
|
2006-12-21 |
2019-02-28 |
Paratek Pharmaceuticals, Inc. |
Substituirane spojine tetraciklina za zdravljenje vnetnih kožnih motenj
|
|
GB0703627D0
(en)
|
2007-02-24 |
2007-04-04 |
Agt Sciences Ltd |
Aqueous formulations
|
|
US20100016322A1
(en)
|
2007-02-28 |
2010-01-21 |
Nagesh Nagaraju |
Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
|
|
CN102688492A
(zh)
|
2007-03-23 |
2012-09-26 |
分子研究中心公司 |
包含四环素类的抗炎组合物及其用途
|
|
CN101795669A
(zh)
|
2007-07-11 |
2010-08-04 |
陶氏康宁公司 |
用于递送药物的组合物
|
|
CN101380474B
(zh)
|
2007-09-06 |
2012-07-25 |
北京大学 |
用于口服制剂的pH敏感性固体药物组合物及制备方法
|
|
US20090181068A1
(en)
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
|
EP2133071A1
(en)
|
2008-06-09 |
2009-12-16 |
Université de la Méditerranée |
Process for making gastroretentive dosage forms
|
|
AU2009272280B2
(en)
|
2008-07-14 |
2015-08-06 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
WO2010017215A2
(en)
|
2008-08-04 |
2010-02-11 |
The Regents Of The University Of California |
Biodegradable microspheres and methods of use thereof
|
|
US20120028929A1
(en)
|
2008-09-19 |
2012-02-02 |
Alacrity Bioscience, Inc. |
Tetracycline stabilizing formulations
|
|
EP2346351B1
(en)
|
2008-09-22 |
2019-07-03 |
Rubicon Research Private Limited |
Compositions exhibiting delayed transit through the gastrointestinal tract
|
|
DE102008048729A1
(de)
|
2008-09-24 |
2010-03-25 |
Add Technologies Ltd Advanced Drug Delivery |
Multipartikuläre Tabletten und Verfahren zur deren Herstellung
|
|
WO2010035273A2
(en)
|
2008-09-29 |
2010-04-01 |
Intec Pharma Ltd. |
Novel gastroretentive delivery system
|
|
WO2010038234A1
(en)
|
2008-10-02 |
2010-04-08 |
Taro Pharmaceutical Industries Ltd. |
Combination product of spironolactone and doxycycline
|
|
EP2331209A1
(en)
|
2008-10-02 |
2011-06-15 |
Bayer Consumer Care AG |
Compositions for treating or alleviating skin diseases or disorders related to an enhanced level of anti-microbial peptides and proteins
|
|
US9498431B2
(en)
|
2008-12-10 |
2016-11-22 |
Jianjian Xu |
Controlled releasing composition
|
|
JP5723287B2
(ja)
|
2008-12-15 |
2015-05-27 |
バナー ライフ サイエンシズ エルエルシー |
非水溶性活性薬剤の放出および吸収を増強するための方法
|
|
WO2010120892A2
(en)
|
2009-04-14 |
2010-10-21 |
The Regents Of The University Of California |
Improved oral drug devices and drug formulations
|
|
GB0907019D0
(en)
|
2009-04-24 |
2009-06-03 |
Oxford Nutrascience Ltd |
Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
|
|
US20100291201A1
(en)
|
2009-05-14 |
2010-11-18 |
Cerovene, Inc. |
Coated pharmaceutical capsule dosage form
|
|
JP2012528197A
(ja)
|
2009-05-28 |
2012-11-12 |
ノースウエスタン ユニバーシティ |
ナノダイヤモンド粒子複合体
|
|
EP2485742A4
(en)
|
2009-10-06 |
2013-03-20 |
Scott Dorfner |
ANTIBIOTIC FORMULATIONS WITH REDUCED SIDE EFFECTS ON STOMACH AND DARM
|
|
PT2493474T
(pt)
|
2009-10-30 |
2019-11-26 |
Intratus Inc |
Métodos e composições para libertação prolongada de fármacos
|
|
US9327105B2
(en)
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
US20120076742A1
(en)
|
2010-04-21 |
2012-03-29 |
Phillips D Howard |
Topical drug delivery system with dual carriers
|
|
JP5865360B2
(ja)
|
2010-06-11 |
2016-02-17 |
プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． |
油分高濃度配合軟化性エアロゾル発泡組成物
|
|
US20120100214A1
(en)
|
2010-10-21 |
2012-04-26 |
Galderma S.A. |
Sustained-Release Tablet and Process for Preparing the Same
|
|
US8652516B1
(en)
|
2013-03-15 |
2014-02-18 |
Cerovene, Inc. |
Doxycycline formulations, and methods of treating rosacea
|